Source comparison
Quickcomparison
Dose Range Apelin-13 As prescribed–As prescribed mg BPC-157 250–500 mcg Frequency Once daily Administration Intravenous (IV) Subcutaneous injection Cycle Length Ongoing/indefinite 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials
This comparison does not assign a generated winner or score.
- Dose Range
- Apelin-13
- As prescribed–As prescribed mg
- BPC-157
- 250–500 mcg
- Frequency
- Once daily
- Administration
- Intravenous (IV)
- Subcutaneous injection
- Cycle Length
- Ongoing/indefinite
- 4-6 weeks
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Strong preclinical (extensive animal studies)
- Efficacy